Spiking-and-Recovery Experiment DOREMI Study
NCT02622347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2017-05-16
Summary
The purpose of this study is to test the validity of our in-house chemiluminescence assay for measurement of folliclestimulating hormone (FSH) serum levels before and during exogenous recombinant FSH (rFSH) administration.
Conditions
- FSH Assay
Sponsors & Collaborators
-
UMC Utrecht
lead OTHER
Principal Investigators
-
Broekmans · UMC Utrecht
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2017-04-30
- Completion
- 2017-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit
NCT02294773 ·Status: COMPLETED ·Phase: NA
-
An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen
NCT01080729 ·Status: TERMINATED
-
Diagnostic Value of Sperm DNA Fragmentation and Sperm Morphology for Assisted Reproduction Treatment
NCT02520869 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®
NCT01794208 ·Status: COMPLETED ·Phase: PHASE2
-
What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation?
NCT00492934 ·Status: UNKNOWN ·Phase: NA
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium
NCT00976651 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733 ·Status: COMPLETED
-
Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
NCT04168892 ·Status: COMPLETED
-
Assessment of the Therapeutic Utility of hMG-HP
NCT01330784 ·Status: COMPLETED
-
Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination.
NCT00820482 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Dose FSH-GEX(TM) in Healthy Volunteers
NCT01477073 ·Status: COMPLETED ·Phase: PHASE1
-
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
NCT04487925 ·Status: RECRUITING ·Phase: PHASE4
-
Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
NCT06572930 ·Status: RECRUITING
-
Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles
NCT01785095 ·Status: COMPLETED ·Phase: PHASE3
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
NCT02309671 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of FSH on Endothelial Function (FEND)
NCT04430621 ·Status: UNKNOWN ·Phase: PHASE4
-
A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
NCT01426386 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
NCT00257556 ·Status: COMPLETED ·Phase: PHASE4
-
FSH Followed by HMG vs FSH Plus HMG in IVF
NCT04385342 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of the Effectiveness of Menopur in Intrauterine Insemination
NCT01354834 ·Status: COMPLETED
-
Androgenic Profile Following Controlled Ovarian Stimulation
NCT02992808 ·Status: UNKNOWN ·Phase: PHASE4
-
Hormone Evaluation in Artificial Reproductive Technology
NCT03737253 ·Status: COMPLETED ·Phase: NA
-
150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial
NCT07346235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3